Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
2011 · Science Translational Medicine · 661 citations
https://doi.org/10.1126/scitranslmed.3002442
A
Annarita Destro
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
6.1K
Citations
35
h-index
47
i10-index
Annarita Destro is an academic researcher from Policlinico Umberto I. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Colorectal Cancer Treatments and Studies & Neuroendocrine Tumor Research Advances. The author has an h-index of 35, co-authored 92 publications.
ORCID: 0000-0001-5388-0353Papers by this author
worksIncreased <i>MET</i> Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
2009 · Journal of Clinical Oncology · 550 citations
https://doi.org/10.1200/jco.2008.19.1635
A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
2009 · American Journal of Respiratory and Critical Care Medicine · 378 citations
https://doi.org/10.1164/rccm.200901-0076oc
Lung cancer screening with spiral CT
2007 · Lung Cancer · 194 citations
https://doi.org/10.1016/j.lungcan.2007.08.040
Modular Structure of the Human Lamin B2 Replicator
2004 · Molecular and Cellular Biology · 92 citations
https://doi.org/10.1128/mcb.24.7.2958-2967.2004
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer
2006 · British Journal of Cancer · 86 citations
https://doi.org/10.1038/sj.bjc.6603337
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat